Gender Dysphoria Prescribing and Monitoring Local Enhanced Service

Concepts

• health services
• nottingham
• prescribing hormone treatments
• gender dysphoria
• monitoring local enhanced service
• gender dysphoria services
• gender dysphoria prescribing
• local
• monitoring
• dysphoria

Location

Nottingham:

Description

Prescribing hormone treatments for transgender patients who are experiencing gender dysphoria

Total Quantity or Scope

Services to be provided - Prescribing hormone treatments for transgender patients who are experiencing gender dysphoria. This notice is confirmation of an award having been made due to an urgent circumstance. The contract is activity based. The dates between which the service will be provided is 1 April 2025 to 31 March 2026.

Award Detail

Renewal Options

Award of a contract without prior publication of a call for competition

Award Criteria

CPV Codes

• 85100000 - Health services

Indicators

• Options are available.

Legal Justification

This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The award has been made under an urgent circumstances as existing providers are suddenly unable to deliver services and new service providers need to be identified. The ICB needed to act rapidly in an unforeseen circumstance not attributable to the authority. The decision was made by the Primary Medical Services Contracting Panel in line with the ICB's Scheme of Reservation and Delegation. No conflicts of interest were identified.